NHSA welcomes multimillion pound clinical trials investment
New investment in UK clinical research welcomed by NHSA Chief Executive
2nd September 2024
Following the government’s announcement of a joint public-private investment programme worth up to £400million to strengthen clinical trials and improve medicines manufacturing in the UK, the NHSA’s Chief Executive, Hannah Davies, has welcomed the ‘much-needed’ investment.
Hannah said: “We are delighted to see the importance of health research recognised with this much-needed investment, which will not only help to improve patient care and health outcomes but also bring economic benefits to the UK health and life sciences sector.
“Our analysis of health research spending exposed the persisting regional imbalance in health research funding, with the North losing out on millions of pounds compared to the Greater South East. We hope that this new investment will be spread fairly across the UK so the North’s health research excellence, and proven capabilities in delivering clinical trials, have the opportunity to thrive and compete on a global scale.”
Related News Articles
GALLERY: Labour Party Conference 2024
A summary and gallery from the 2024 Labour Party Conference
Read the articleVast inequalities faced by women in the North of England exposed in report
Health Equity North has released the Woman of the North report
Read the articleRegional inequalities in Long Covid rates revealed
A fifth of patients in some areas of the North of England have Long Covid, according to research released today (Friday 23rd August 2024) by Health Equity North.
Read the article